ATE481403T1 - Substituierte 1-phenyl-1,5-dihydro-pyridoä3,2- büindol-2-on-derivate verwendbar als pharmazeutische antiinfektiva - Google Patents

Substituierte 1-phenyl-1,5-dihydro-pyridoä3,2- büindol-2-on-derivate verwendbar als pharmazeutische antiinfektiva

Info

Publication number
ATE481403T1
ATE481403T1 AT05747918T AT05747918T ATE481403T1 AT E481403 T1 ATE481403 T1 AT E481403T1 AT 05747918 T AT05747918 T AT 05747918T AT 05747918 T AT05747918 T AT 05747918T AT E481403 T1 ATE481403 T1 AT E481403T1
Authority
AT
Austria
Prior art keywords
pyridoä3
büindol
antiinfectives
dihydro
phenyl
Prior art date
Application number
AT05747918T
Other languages
English (en)
Inventor
Bart Kesteleyn
Sandrine Vendeville
Natalie Kindermans
Dominique Surleraux
Pierre Jean-Marie Raboisson
Piet Wigerinck
Annick Ann Peeters
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Application granted granted Critical
Publication of ATE481403T1 publication Critical patent/ATE481403T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT05747918T 2004-05-17 2005-05-17 Substituierte 1-phenyl-1,5-dihydro-pyridoä3,2- büindol-2-on-derivate verwendbar als pharmazeutische antiinfektiva ATE481403T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04102170 2004-05-17
PCT/EP2005/052263 WO2005111035A1 (en) 2004-05-17 2005-05-17 6,7,8,9-substituted 1-phenyl-1,5-dihydro-pyrido[3,2-b]indol-2-ones useful as anti-infective pharmaceutical agents

Publications (1)

Publication Number Publication Date
ATE481403T1 true ATE481403T1 (de) 2010-10-15

Family

ID=34929105

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05747918T ATE481403T1 (de) 2004-05-17 2005-05-17 Substituierte 1-phenyl-1,5-dihydro-pyridoä3,2- büindol-2-on-derivate verwendbar als pharmazeutische antiinfektiva

Country Status (14)

Country Link
US (2) US7622581B2 (de)
EP (1) EP1751156B1 (de)
JP (1) JP2007538050A (de)
CN (1) CN1976930B (de)
AR (1) AR049637A1 (de)
AT (1) ATE481403T1 (de)
BR (1) BRPI0511173A (de)
DE (1) DE602005023600D1 (de)
ES (1) ES2351702T3 (de)
MX (1) MXPA06013313A (de)
PL (1) PL1751156T3 (de)
RU (1) RU2377243C2 (de)
TW (1) TW200607502A (de)
WO (1) WO2005111035A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7994187B2 (en) 2006-04-03 2011-08-09 Tibotec Pharmaceuticals Ltd. HIV inhibiting 3,4-dihydro-imidazo[4,5-B]pyridin-5-ones
WO2008037783A1 (en) * 2006-09-29 2008-04-03 Tibotec Pharmaceuticals Ltd. Process for preparing 2-oxo-2,5-dihydro-1h-pyrido[3,2-b]indole-3-carbonitriles
CA2758149A1 (en) 2009-04-09 2010-10-14 Boehringer Ingelheim International Gmbh Inhibitors of hiv replication
AU2011252351A1 (en) * 2010-05-14 2012-10-11 Affectis Pharmaceuticals Ag Novel methods for the preparation of P2X7R antagonists
RU2451680C1 (ru) 2011-02-21 2012-05-27 Общество С Ограниченной Ответственностью "Научно-Исследовательская Компания "Медбиофарм" Клатратный комплекс циклодекстрина или арабиногалактана с 9-фенил-симм-октагидроселеноксантеном, способ его получения (варианты), фармацевтическая композиция и лекарственное средство
RU2464042C1 (ru) * 2011-03-31 2012-10-20 Общество С Ограниченной Ответственностью "Научно-Исследовательская Компания "Медбиофарм" КЛАТРАТНЫЙ КОМПЛЕКС β-ЦИКЛОДЕКСТРИНА С ПРОИЗВОДНЫМ 5-ГИДРОКСИ-4-АМИНОМЕТИЛ-1-ЦИКЛОГЕКСИЛ(ИЛИ ЦИКЛОГЕПТИЛ)-3-АЛКОКСИКАРБОНИЛИНДОЛА, СПОСОБ ЕГО ПОЛУЧЕНИЯ (ВАРИАНТЫ), ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И ЛЕКАРСТВЕННОЕ СРЕДСТВО
WO2013037705A2 (en) 2011-09-16 2013-03-21 Fovea Pharmaceuticals Aniline derivatives,their preparation and their therapeutic application
RU2640081C1 (ru) * 2016-07-11 2017-12-26 Общество с ограниченной ответственностью "ЛАЙФ САЙНСЕС ОХФК" Фармацевтическая композиция и лекарственное средство на основе клатратного комплекса N-карбамоилметил-4-фенил-2-пирролидон или 4-фенилпирацетам с циклодекстрином, способы его получения (варианты)
EP3768882B1 (de) * 2018-03-20 2023-02-22 Compagnie Generale Des Etablissements Michelin Verbesserter aramidtextilkord mit mindestens einer dreifachen verdrillung
CN108530381B (zh) * 2018-05-07 2021-09-21 上海科技大学 一种由酰胺酯制备二胺衍生物的方法
US20240208984A1 (en) * 2021-03-31 2024-06-27 Virginia Commonwealth University Bivalent ligands to understand dimerization of the mu opioid receptor and the chemokine receptor ccr5 in neurological disorders

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB427857A (en) 1934-08-02 1935-05-01 Newsum Sons & Company Ltd H A new or improved system of construction for skeleton structures, particularly vehicle body frames and door frames
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
PH30929A (en) 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
IL111080A (en) 1993-10-01 1999-08-17 Astra Ab Method for treating a finely divided powder medicament
RU2140417C1 (ru) * 1995-10-17 1999-10-27 Институт физиологически активных веществ РАН Производные гидрированных пиридо(4,3-b)индолов, способы их получения, фармацевтическая композиция и способ лечения
EA001219B1 (ru) 1996-05-20 2000-12-25 Жансен Фармасетика Н.В. Антигрибковые композиции с улучшенной биологической доступностью
WO1998042318A1 (en) 1997-03-26 1998-10-01 Janssen Pharmaceutica N.V. Pellets having a core coated with an antifungal and a polymer
WO2002059123A2 (en) * 2000-12-18 2002-08-01 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
US20020182151A1 (en) * 2000-12-18 2002-12-05 The Government Of The U.S.A. As Represented By The Secretary Of The Dept. Of Health & Human Services Benzoylalkylindolepyridinium componds and pharmaceutical compositions comprising such compounds
ES2278064T3 (es) * 2001-10-19 2007-08-01 Transtech Pharma Inc. Derivados de beta-carbolina como inhibidores de ptp.
AU2003296760B2 (en) * 2002-11-15 2009-11-19 Tibotec Pharmaceuticals Ltd. Substituted indolepyridinium as anti-infective compounds

Also Published As

Publication number Publication date
CN1976930B (zh) 2011-01-19
CN1976930A (zh) 2007-06-06
EP1751156A1 (de) 2007-02-14
RU2377243C2 (ru) 2009-12-27
US20100029635A1 (en) 2010-02-04
BRPI0511173A (pt) 2007-12-04
EP1751156B1 (de) 2010-09-15
JP2007538050A (ja) 2007-12-27
PL1751156T3 (pl) 2011-03-31
WO2005111035A1 (en) 2005-11-24
RU2006144852A (ru) 2008-06-27
MXPA06013313A (es) 2007-02-02
AR049637A1 (es) 2006-08-23
ES2351702T3 (es) 2011-02-09
DE602005023600D1 (de) 2010-10-28
US20070167434A1 (en) 2007-07-19
US7622581B2 (en) 2009-11-24
TW200607502A (en) 2006-03-01

Similar Documents

Publication Publication Date Title
HUS1900034I1 (hu) 6,7-telítetlen-7-karbamoil-szubsztituált morfinán-származékok
EP1748765A4 (de) Pharmazeutische suspensionszusammensetzung
BRPI0618904A2 (pt) composto, composição farmacêutica, e, uso do composto
BRPI0614205A2 (pt) composto, composição farmacêutica, e, uso de composto
EP1992348A4 (de) Pharmazeutische kombination
NO20075628L (no) Farmasøytiske formuleringer
DE502004003234D1 (de) Gegen missbrauch gesicherte darreichungsform
DE502004004205D1 (de) Gegen missbrauch gesicherte darreichungsform
ATE415400T1 (de) Pyrazolopyridinderivate
ATE394399T1 (de) Tetrahydropyridoindolderivate
ATE383361T1 (de) Pyrrazolopyrimidinderivate
SMP200800029B (it) 2-ammino-7,8-diidro-6h-pirido[4,3-d]pirimidin-5-oni
DK1753764T3 (da) Pyrrolopyridin-derivater
DK1957073T3 (da) Lægemiddel
DK2033629T3 (da) Fast farmaceutisk sammensætning omfattende valsartan
ATE481403T1 (de) Substituierte 1-phenyl-1,5-dihydro-pyridoä3,2- büindol-2-on-derivate verwendbar als pharmazeutische antiinfektiva
ATE483702T1 (de) Neue pharmazeutische verbindungen
NL2000336A1 (nl) Spirocyclische derivaten.
DE602006018645D1 (de) 3-monosubstituiertes tropan-derivat als nociceptinrezeptor-ligand
ATE365731T1 (de) 4-amino-5-cyanopyrimidinderivate
ITMI20041447A1 (it) Composizione farmaceutica comprendente gabapentina
ITMI20051155A1 (it) Nuovi composti fluorurati, loro sintesi e uso.
EP1889613A4 (de) Pharmazeutische zusammensetzung mit vitamin k
ATE489943T1 (de) Pharmazeutische zusammensetzung mit 2,3-dihydro-6-nitroimidazoä2,1-büoxazolderivate
ATE369347T1 (de) Trimere makrocyclisch substituierte halogen- benzolderivate

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties